Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence are working to change that. They have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies. Their findings were published in Clinical Cancer Research. You can read about it more at : https://m.medicalxpress.com/news/2019-07-effective-drug-combination-uvea...